Rationality of routine clinical use of olokizumab in COVID-19
Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials.
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Izdatelstvo OKI
2020-10-01
|
| Series: | Качественная клиническая практика |
| Subjects: | |
| Online Access: | https://www.clinvest.ru/jour/article/view/530 |
| _version_ | 1797262022698598400 |
|---|---|
| author | V. M. Tsvetov A. V. Matveev D. A. Sychev |
| author_facet | V. M. Tsvetov A. V. Matveev D. A. Sychev |
| author_sort | V. M. Tsvetov |
| collection | DOAJ |
| description | Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials. |
| first_indexed | 2024-04-24T23:50:30Z |
| format | Article |
| id | doaj.art-1b429c37cc9a4d7cbc00aad081552c14 |
| institution | Directory Open Access Journal |
| issn | 2588-0519 2618-8473 |
| language | Russian |
| last_indexed | 2024-04-24T23:50:30Z |
| publishDate | 2020-10-01 |
| publisher | Izdatelstvo OKI |
| record_format | Article |
| series | Качественная клиническая практика |
| spelling | doaj.art-1b429c37cc9a4d7cbc00aad081552c142024-03-14T18:09:09ZrusIzdatelstvo OKIКачественная клиническая практика2588-05192618-84732020-10-0104S687010.37489/2588-0519-2020-S4-68-70514Rationality of routine clinical use of olokizumab in COVID-19V. M. Tsvetov0A. V. Matveev1D. A. Sychev2ФГБУ «Федеральный центр сердечно-сосудистой хирургии» Минздрава РоссииФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииRoutine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials.https://www.clinvest.ru/jour/article/view/530коронавирусолокизумабcovid-19 |
| spellingShingle | V. M. Tsvetov A. V. Matveev D. A. Sychev Rationality of routine clinical use of olokizumab in COVID-19 Качественная клиническая практика коронавирус олокизумаб covid-19 |
| title | Rationality of routine clinical use of olokizumab in COVID-19 |
| title_full | Rationality of routine clinical use of olokizumab in COVID-19 |
| title_fullStr | Rationality of routine clinical use of olokizumab in COVID-19 |
| title_full_unstemmed | Rationality of routine clinical use of olokizumab in COVID-19 |
| title_short | Rationality of routine clinical use of olokizumab in COVID-19 |
| title_sort | rationality of routine clinical use of olokizumab in covid 19 |
| topic | коронавирус олокизумаб covid-19 |
| url | https://www.clinvest.ru/jour/article/view/530 |
| work_keys_str_mv | AT vmtsvetov rationalityofroutineclinicaluseofolokizumabincovid19 AT avmatveev rationalityofroutineclinicaluseofolokizumabincovid19 AT dasychev rationalityofroutineclinicaluseofolokizumabincovid19 |